This document proposes a therapeutic scheme for treating oligospermia based on serum levels of FSH and estradiol. Six groups of oligospermia are identified based on different combinations of FSH and estradiol levels. These include idiopathic, spermatogenic deficiency, estrogen resistance, estrogen excess, hypogonadotropism, and aromatase deficiency. Depending on which group a patient falls into based on their hormone levels, different treatments are recommended. The goal is to develop an evidence-based approach to identify the most suitable therapy for oligospermia before beginning treatment.